CJC-1295 / Ipa (No DAC)

10 × 10mg

A growth-hormone-releasing hormone analog. Studied for its stable, long-acting stimulation of endogenous GH pulses without desensitization.

$599.90

$419.90

Save $180.00

Pay for 7 vials, receive 10 — $41.99 per vial instead of $59.99.

Every pack earns rewards points · free shipping over $100

Buy a single vial Research guide

About CJC-1295 / Ipa (No DAC)

CJC-1295 is a modified GHRH(1-29) analog stabilized by four amino-acid substitutions. Those substitutions block the enzymatic degradation that typically chews through native GHRH in minutes, producing a peptide with a measurably longer half-life. The mechanism researchers care about: CJC-1295 triggers the pituitary’s own GH release machinery rather than supplying exogenous GH. Published data show preserved diurnal GH pulsatility — important because tonic GH exposure causes receptor desensitization, while pulsatile exposure does not. IF the research question is endogenous GH-axis modulation with preserved pulsatility, THEN CJC-1295 is the GHRH analog with the cleanest published pharmacology. SO it belongs in protocols studying IGF-1 response, sleep-wave modulation, or GH/IGF-1-axis physiology. ≥99% purity, batch-tested, CoA included.

Specifications

CAS number: 863288-34-0
Molecular formula: C152H252N44O42
Molecular weight: 3367.20 g/mol
Purity: >99% HPLC
Form: Lyophilized powder
Storage: Store at 2–8°C

For laboratory research use only. Not for human or veterinary use.